Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2021 | 591.83M |
| December 31, 2020 | 476.88M |
| September 30, 2020 | 459.62M |
| June 30, 2020 | 357.41M |
| March 31, 2020 | 509.46M |
| December 31, 2019 | 365.93M |
| Date | Value |
|---|---|
| September 30, 2019 | 477.19M |
| June 30, 2019 | 350.75M |
| March 31, 2019 | 531.88M |
| December 31, 2018 | 365.24M |
| September 30, 2018 | 398.94M |
| June 30, 2018 | 317.07M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
350.75M
Minimum
Jun 2019
591.83M
Maximum
Mar 2021
448.63M
Average
468.25M
Median
Revenue (Quarterly) Benchmarks
| Revolution Medicines Inc | -- |
| Zentalis Pharmaceuticals Inc | 40.56M |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 13.87M |
| Xtant Medical Holdings Inc | 27.87M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.41M |
| Total Expenses (Quarterly) | 66.77M |
| EPS Diluted (Quarterly) | -0.72 |
| Enterprise Value | 1.095B |
| Earnings Yield | -15.52% |
| Operating Earnings Yield | 19.00% |
| Normalized Earnings Yield | 13.10 |